Benzinga | Jan 26, 2021 06:10AM EST

Piper Sandler Downgrades Repro-Med Systems to Neutral, Lowers Price Target to $4.5

Piper Sandler analyst Matthew O'Brien downgrades Repro-Med Systems (NASDAQ:KRMD) from Overweight to Neutral and lowers the price target from $9 to $4.5.